Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Illumina Inc (NQ: ILMN )

239.44 -0.82 (-0.34%)
Streaming Delayed Price Updated: 11:55 AM EDT, May 25, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 254,961
Open 237.94
Bid (Size) 239.33 (1)
Ask (Size) 239.53 (1)
Prev. Close 240.26
Today's Range 237.77 - 242.43
52wk Range 208.35 - 526.00
Shares Outstanding 146,700,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Illumina Introduces New Pan-Cancer Companion Diagnostic to Match Patients With Rare Genetic Mutations to Targeted Therapy
SOURCE: Illumina 
Via 3BL Media
Illumina Ventures Announces Promotion and Additions to its Investment Team
From Illumina Ventures
Via Business Wire

Performance

YTD
-37.13%
-37.13%
1 Month
-24.96%
-24.96%
3 Month
-25.14%
-25.14%
6 Month
-34.53%
-34.53%
1 Year
-40.14%
-40.14%

More News

Read More
Illumina Employees Volunteer Their Time at Over 100 Events in Celebration of Global Volunteer Month
Via 3BL Media
Illumina and Allegheny Health Network to Assess In-House Comprehensive Cancer Genomic Profiling to Enhance Patient Care
Via 3BL Media
Illumina Partners With Allelica, Inc.
Via 3BL Media
Why Illumina Shares Are Plunging Today?
Via Benzinga
Illumina Reports 41% Dip In Q1 Profits Despite 12% Jump in Sales, Reaffirms FY22 Guidance
Via Benzinga
9 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Illumina Named Top 100 Best Corporate Citizens and Ranked #1 in the Employee Category
Via 3BL Media
Topics Emissions
DNA sequencing Market Qualitative Insights on Application & Outlook by Share, Future Growth
Via iCrowdNewswire
GRAIL and Intermountain Healthcare Expand Partnership to Offer Galleri® Multi-Cancer Early Detection Blood Test to Eligible Patients in Utah
From GRAIL, LLC
Via Business Wire
Illumina Crushes Earnings Forecast, Though Sales Only Meet Expectations
Via Investor's Business Daily
10 Biggest Price Target Changes For Monday
Via Benzinga
Bioinformatics Market Analysis Covering Size, Growth, Trends and Upcoming Opportunities
Via iCrowdNewswire
BioForward Hosts Wisconsin Biohealth Opportunities Career Fair
Via iCrowdNewswire
Where Illumina Stands With Analysts
Via Benzinga
Illumina and Deerfield Management Partner to Accelerate Drug Development
Via 3BL Media
Topics Artificial Intelligence
Exposures Artificial Intelligence
92 Biggest Movers From Friday
Via Benzinga
If You Invested $1000 In Ilumina 10 Years Ago, Here's How Much You Would Have Today
Via Benzinga
55 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Cambridge Launchpad As Illumina Targets Five Million STEM Learners
Via 3BL Media
World Must Leverage Genomics to Fight Pandemics, Illumina CEO Says
Via 3BL Media
Topics Economy
Exposures Economy
The Week Ahead In Biotech (May 1-7): Phathom FDA Decision, Pfizer, Vertex Pharma Lead Earnings News, Ophthalmology Conference Presentations, And More
Via Benzinga
Illumina Announces Long-Term Strategic Partnership with Janssen
Via 3BL Media
How Collaboration Is Driving the Next Wave of Genomics
Via 3BL Media
Exposures COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.